Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAT2A | P31153 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 3/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.31 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22472473 | 0.94 | MAT2A (0.32) | MAT2ANPC1RAB9AKMT2A | |
| SCHEMBL22472385 | 0.78 | ADORA2A (0.40) | NPC1RAB9AMAPTSMN1; SMN2NPSR1 | |
| SCHEMBL22472452 | 0.72 | KDM4E (0.40) | NPC1RAB9AMAPTSMN1; SMN2NPSR1 | |
| SCHEMBL22472368 | 0.69 | NPC1 (0.47) | NPC1RAB9AMAPTNPSR1KMT2A | |
| SCHEMBL22472519 | 0.68 | BACE1 (0.36) | BACE1KMT2A | |
| SCHEMBL22472520 | 0.66 | NPY5R (0.31) | — | |
| SCHEMBL22472394 | 0.66 | NPC1 (0.42) | NPC1RAB9AMAPTSMN1; SMN2NPSR1 | |
| SCHEMBL22472521 | 0.64 | TNK2 (0.31) | SMN1; SMN2NFKB1NFKB2RELAALDH1A1 | |
| SCHEMBL22472388 | 0.64 | KDM4E (0.34) | NPC1RAB9AMAPTSMN1; SMN2NPSR1 | |
| SCHEMBL9611675 | 0.60 | ADORA2A (0.50) | NPC1RAB9ABACE1KMT2AADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10790455-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10790455-B2 | Organic electroluminescent materials and devices | ORC3, ALKBH2, ENPP3 | MAT2A 2473/4885NPC1 4454/4885RAB9A 2730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.